Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (484) 484
humans (458) 458
pregnancy (446) 446
female (443) 443
preeclampsia (403) 403
soluble endoglin (307) 307
obstetrics & gynecology (267) 267
adult (259) 259
hypertension (180) 180
vascular endothelial growth factor receptor-1 - blood (176) 176
placental growth factor (158) 158
pre-eclampsia - blood (157) 157
angiogenic factors (145) 145
vascular endothelial growth factor (132) 132
placenta growth factor (131) 131
biomarkers - blood (129) 129
pre-eclampsia (128) 128
angiogenesis (122) 122
endothelial growth-factor (121) 121
endoglin (119) 119
tyrosine kinase-1 (113) 113
pregnancy proteins - blood (111) 111
risk (108) 108
tyrosine (108) 108
women (104) 104
animals (103) 103
case-control studies (103) 103
obstetrics and gynecology (96) 96
pre-eclampsia - diagnosis (96) 96
placenta (95) 95
expression (93) 93
pregnant women (93) 93
soluble fms-like tyrosine kinase 1 (93) 93
soluble fms-like tyrosine kinase-1 (91) 91
risk factors (86) 86
peripheral vascular disease (85) 85
prospective studies (83) 83
analysis (76) 76
pre-eclampsia - metabolism (74) 74
uterine artery doppler (70) 70
vascular endothelial growth factor receptor-1 - metabolism (70) 70
reproductive biology (69) 69
placental growth-factor (68) 68
article (66) 66
gestational age (65) 65
antiangiogenic factors (64) 64
pre-eclampsia - physiopathology (64) 64
young adult (64) 64
abridged index medicus (63) 63
hypertensive disorders (59) 59
pre‐eclampsia (59) 59
biomarkers (58) 58
health aspects (58) 58
placenta - metabolism (58) 58
enzyme-linked immunosorbent assay (57) 57
pathogenesis (55) 55
embryonic structures (54) 54
predictive value of tests (54) 54
male (53) 53
sflt-1 (52) 52
receptors, cell surface - blood (51) 51
antigens, cd - blood (49) 49
endothelium (49) 49
vegf (49) 49
infant, newborn (47) 47
pre-eclampsia - etiology (47) 47
prediction (45) 45
growth-factor (43) 43
mice (43) 43
diagnosis (42) 42
soluble fms‐like tyrosine kinase‐1 (42) 42
factor receptor-1 (41) 41
growth factors (41) 41
research (41) 41
blood pressure (40) 40
internal medicine (40) 40
proteins (40) 40
vascular endothelial growth factor a - blood (40) 40
hypoxia (39) 39
immunology (39) 39
vascular endothelial growth factor receptor-1 - genetics (39) 39
oxidative stress (38) 38
pregnancy outcome (38) 38
circulating angiogenic factors (37) 37
physiology (37) 37
sensitivity and specificity (37) 37
inflammation (35) 35
placenta growth factor - blood (35) 35
proteinuria (35) 35
acoustics (34) 34
developmental biology (34) 34
medicine (34) 34
radiology, nuclear medicine & medical imaging (34) 34
normal-pregnancy (33) 33
prognosis (33) 33
physiological aspects (32) 32
tyrosine kinase 1 (32) 32
vascular endothelial growth factor a - metabolism (32) 32
blood-pressure (31) 31
cells (31) 31
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction
by Brownfoot, Fiona C., MBBS and Hastie, Roxanne, BBiomed Sc and Hannan, Natalie J., B Sci, PhD and Cannon, Ping, B Sci and Tuohey, Laura, BSci and Parry, Laura J., B Sci, PhD and Senadheera, Sevvandi, B Sci PhD and Illanes, Sebastian E., MBBS, MSc and Kaitu’u-Lino, Tu’uhevaha J., PhD and Tong, Stephen, MBBS, PhD
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 214, Issue 3, pp. 356.e1 - 356.e15
Background Preeclampsia is associated with placental ischemia/hypoxia and secretion of soluble fms-like tyrosine kinase 1 and soluble endoglin into the... 
Obstetrics and Gynecology | soluble fms-like tyrosine kinase 1 | metformin | electron transport chain | preeclampsia | soluble endoglin | NORMAL-PREGNANCY | ADHESION MOLECULES | HYPOXIA | ANGIOGENIC FACTORS | GUANYLATE-CYCLASE | OBSTETRICS & GYNECOLOGY | WOMEN | HYPERTENSION | EXPRESSION | PLACENTAL MITOCHONDRIAL CONTENT | SFLT-1 | Metformin - therapeutic use | Humans | Endothelium, Vascular - drug effects | Pre-Eclampsia - physiopathology | Antigens, CD - metabolism | Endoglin | Pre-Eclampsia - prevention & control | Female | Pre-Eclampsia - metabolism | Biomarkers - metabolism | Metformin - pharmacology | Endothelium, Vascular - physiopathology | Receptors, Cell Surface - metabolism | Treatment Outcome | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Cardiovascular Agents - pharmacology | Placenta - drug effects | Placenta - metabolism | Pregnancy | Cardiovascular Agents - therapeutic use | Pre-Eclampsia - drug therapy | Endothelium, Vascular - metabolism | Electron Transport Chain Complex Proteins - metabolism | Vasodilation - drug effects | In Vitro Techniques | Hypertension | Prevention | Tyrosine | Care and treatment | Preeclampsia | Phenols | Metformin | Diabetes therapy | Endothelium | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis
by Kleinrouweler, CE and Wiegerinck, MMJ and Ris‐Stalpers, C and Bossuyt, PMM and van der Post, JAM and von Dadelszen, P and Mol, BWJ and Pajkrt, E and EBM CONNECT Collaboration
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 06/2012, Volume 119, Issue 7, pp. 778 - 787
Please cite this paper as: Kleinrouweler C, Wiegerinck M, Ris‐Stalpers C, Bossuyt P, van der Post J, von Dadelszen P, Mol B, Pajkrt E, for the EBM CONNECT... 
placental growth factor | Biomarkers | pre‐eclampsia | vascular endothelial growth factor | soluble endoglin | soluble fms‐like tyrosine kinase‐1 | pre-eclampsia | soluble fms-like tyrosine kinase-1 | HYPERTENSIVE DISORDERS | PROSPECTIVE COHORT | OBSTETRICS & GYNECOLOGY | UTERINE ARTERY DOPPLER | ANTIANGIOGENIC FACTORS | ACTIVIN-A | EARLY-ONSET PREECLAMPSIA | EARLY-PREGNANCY | MATERNAL PLASMA | SERUM-LEVELS | ANGIOGENESIS-RELATED FACTORS | Humans | Receptors, Cell Surface - blood | Biomarkers - blood | Pregnancy | Endoglin | Pregnancy Proteins - blood | Antigens, CD - blood | Pre-Eclampsia - blood | Sensitivity and Specificity | Vascular Endothelial Growth Factors - blood | Placenta Growth Factor | Female | Odds Ratio | Vascular Endothelial Growth Factor Receptor-1 - blood | Pre-Eclampsia - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation
by Wewers, Theresa M and Mayer, Anna B and Pfleiderer, Alexander and Beul, Katrin and Schmidt, Rene and Heitplatz, Barbara and Van Marck, Veerle and Nolte, Ingo and Pavenstädt, Hermann and Reuter, Stefan and Brand, Marcus and Di Marco, Giovana S
Kidney International, ISSN 0085-2538, 05/2019, Volume 95, Issue 5, pp. 1091 - 1102
Renal ischemia reperfusion injury (IRI) adversely affects clinical outcomes following kidney transplantation. Understanding the cellular mechanisms and the... 
soluble fms-like tyrosine kinase 1 | microvascular dysfunction | clinical outcomes | ischemia-reperfusion
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
by Rajakumar, Augustine and Cerdeira, Ana Sofia and Rana, Sarosh and Zsengeller, Zsuzsanna and Edmunds, Lia and Jeyabalan, Arun and Hubel, Carl A and Stillman, Isaac E and Parikh, Samir M and Karumanchi, S Ananth
Hypertension, ISSN 0194-911X, 02/2012, Volume 59, Issue 2, pp. 256 - 264
The cardinal manifestations of the pregnancy-specific disorder preeclampsia, new-onset hypertension, and proteinuria that resolve with placental delivery have... 
Syncytial aggregates | SFlt1 | Preeclampsia | Microparticles | Syncytial knots | Soluble VEGFR1 | sFlt1 | NORMAL-PREGNANCY | HEPARIN-BINDING | soluble VEGFR1 | microparticles | SYNCYTIOTROPHOBLAST MICROPARTICLES | preeclampsia | FLT-1 | syncytial knots | PLASMA | REDUCTION | PLACENTAL EXPRESSION | PERIPHERAL VASCULAR DISEASE | syncytial aggregates | TROPHOBLAST DEPORTATION | PROTEINS | GROWTH-FACTOR RECEPTOR-1 | Humans | Pregnancy Complications, Hematologic - blood | Cells, Cultured | Pregnancy | Pregnancy Proteins - blood | RNA, Messenger - blood | Placenta - cytology | Pre-Eclampsia - blood | Cell-Derived Microparticles - pathology | Female | Pregnancy Trimester, Third - blood | Trophoblasts - cytology | Vascular Endothelial Growth Factor Receptor-1 - blood | Organ Culture Techniques
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Increased soluble fms-like tyrosine kinase 1 after c for updates ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation
by Wewers, TM and Mayer, AB and Pfleiderer, A and Beul, K and Schmidt, R and Heitplatz, B and Van Marck, V and Nolte, I and Pavenstadt, H and Reuter, S and Brand, M and Di Marco, GS
KIDNEY INTERNATIONAL, ISSN 0085-2538, 05/2019, Volume 95, Issue 5, pp. 1091 - 1102
Renal ischemia reperfusion injury (IRI) adversely affects clinical outcomes following kidney transplantation. Understanding the cellular mechanisms and the... 
soluble fms-like tyrosine kinase 1 | FACTOR VEGF | ACTIVATION | DELAYED GRAFT FUNCTION | INJURY | RECEPTOR | ischemia-reperfusion | FLT-1 | microvascular dysfunction | clinical outcomes | PERITUBULAR CAPILLARIES | UROLOGY & NEPHROLOGY | DYSFUNCTION | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Threshold of Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio for the Imminent Onset of Preeclampsia
by Ohkuchi, Akihide and Hirashima, Chikako and Matsubara, Shigeki and Takahashi, Kayo and Matsuda, Yoshio and Suzuki, Mitsuaki
Hypertension, ISSN 0194-911X, 11/2011, Volume 58, Issue 5, pp. 859 - 866
It has not been clarified whether thresholds of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), soluble endoglin, and the... 
Soluble fms-like tyrosine kinase 1 | Soluble endoglin | Placental growth factor | Preeclampsia | Prospective cohort study | Prediction | soluble fms-like tyrosine kinase 1 | RISK-FACTORS | prospective cohort study | ENDOGLIN | preeclampsia | RESTRICTION | CIRCULATING ANTIANGIOGENIC FACTORS | PREGNANCY | placental growth factor | UTERINE ARTERY DOPPLER | WOMEN | GESTATIONAL HYPERTENSION | CLINICAL-MANIFESTATIONS | prediction | PERIPHERAL VASCULAR DISEASE | ANGIOGENESIS-RELATED FACTORS | soluble endoglin | Risk Assessment | Humans | Japan | Reference Values | Biomarkers - blood | Gestational Age | Pre-Eclampsia - physiopathology | Case-Control Studies | Pregnancy | Pregnancy Proteins - blood | Time Factors | Pre-Eclampsia - blood | Sensitivity and Specificity | Placenta Growth Factor | Adult | Female | Vascular Endothelial Growth Factor Receptor-1 - blood | Pregnancy Outcome
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Serum soluble fms‐like tyrosine kinase‐1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history
by Tsiakkas, A and Duvdevani, N and Wright, A and Wright, D and Nicolaides, K. H
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 05/2015, Volume 45, Issue 5, pp. 584 - 590
ABSTRACT Objective To define the contribution of maternal variables which influence the measured level of maternal serum soluble fms‐like tyrosine kinase‐1... 
pyramid of pregnancy care | sFlt‐1 | second‐trimester screening | trisomy 21 | third‐trimester screening | pre‐eclampsia | soluble fms‐like tyrosine kinase‐1 | first‐trimester screening | third-trimester screening | sFlt-1 | second-trimester screening | first-trimester screening | pre-eclampsia | soluble fms-like tyrosine kinase-1 | RISK | ANGIOGENIC FACTORS | OBSTETRICS & GYNECOLOGY | ACOUSTICS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Body Mass Index | Medical History Taking | Predictive Value of Tests | Prospective Studies | Humans | United Kingdom | Biomarkers - blood | Gestational Age | Pregnancy | Pregnancy Proteins - blood | Sensitivity and Specificity | Adult | Female | Vascular Endothelial Growth Factor Receptor-1 - blood | Pregnancy Trimesters | Pregnancy Outcome | Tyrosine | Phenols | Pregnant women | Analysis | Smoking | Medical research | Birth weight
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: A possible therapeutic approach to preeclampsia
by Zhao, Y and Zheng, Y.F and Luo, Q.Q and Yan, T and Liu, X.X and Han, L and Zou, L
Placenta, ISSN 0143-4004, 2014, Volume 35, Issue 7, pp. 476 - 482
Abstract Objective To investigate the effects of edaravone, a potent free radical scavenger used clinically, on hypoxia-induced trophoblast-soluble Fms-like... 
Internal Medicine | Obstetrics and Gynecology | Hypoxia | Trophoblasts | Edaravone | Preeclampsia | Soluble Fms-like tyrosine kinase 1 (sFlt-1) | OXIDATIVE STRESS | INDUCIBLE FACTOR | ACUTE LIVER-INJURY | FREE-RADICAL SCAVENGER | DEVELOPMENTAL BIOLOGY | SPIRAL ARTERIES | CELL-DEATH | OBSTETRICS & GYNECOLOGY | OXYGEN | IN-VITRO | REPRODUCTIVE BIOLOGY | ERYTHROPOIETIN GENE | GROWTH-FACTOR RECEPTOR-1 | Free Radical Scavengers - pharmacology | Human Umbilical Vein Endothelial Cells | Pre-Eclampsia - genetics | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Reactive Oxygen Species - metabolism | Gene Expression - drug effects | Antipyrine - pharmacology | Humans | Pregnancy Proteins - genetics | Pregnancy Proteins - metabolism | Vascular Endothelial Growth Factor A - metabolism | RNA, Messenger - metabolism | Vascular Endothelial Growth Factor A - genetics | Trophoblasts - drug effects | Antipyrine - analogs & derivatives | Female | Pre-Eclampsia - metabolism | Vascular Endothelial Growth Factor Receptor-1 - genetics | Cell Line | Cell Hypoxia - drug effects | Trophoblasts - metabolism | RNA, Messenger - genetics | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Pregnancy | Cobalt - toxicity | Pre-Eclampsia - drug therapy | Placenta Growth Factor | Tyrosine | Phenols | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia
by Robinson, Christopher J and Johnson, Donna D and Chang, Eugene Y and Armstrong, D. Michael and Wang, Wei
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2006, Volume 195, Issue 1, pp. 255 - 259
The purpose of this study was to determine if maternal serum concentrations of placenta growth factor (PlGF) and soluble Fms-like tyrosine kinase 1 receptor... 
Pregnancy | Soluble Fms-like tyrosine kinase 1 receptor (s-Flt1) | Placenta growth factor (PlGF) | Preeclampsia | placenta growth factor (PIGF) | soluble Fms-like tyrosine kinase 1 receptor (s-Flt1) | RECEPTOR-BINDING PROPERTIES | ENDOTHELIAL DYSFUNCTION | pregnancy | SERUM-LEVELS | MECHANISMS | preeclampsia | EXPRESSION | OBSTETRICS & GYNECOLOGY | Pregnancy Proteins - blood | Enzyme-Linked Immunosorbent Assay | Humans | Pre-Eclampsia - blood | Placenta Growth Factor | Adult | Female | Vascular Endothelial Growth Factor Receptor-1 - blood | Gestational Age | Pre-Eclampsia - physiopathology | Tyrosine | Phenols | Growth factors | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Exosomes From Women With Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells
by Chang, Xinwen and Yao, Julei and He, Qizhi and Liu, Ming and Duan, Tao and Wang, Kai
Hypertension, ISSN 0194-911X, 12/2018, Volume 72, Issue 6, pp. 1381 - 1390
Preeclampsia is a unique multiple system disorder that affects 5% to 8% of pregnancies. Exosomes, membrane-encapsulated vesicles that are released into the... 
Endoglin | Soluble | Flt1, soluble | Flt1 | Soluble preeclampsia | exosomes | pregnancy | endoglin, soluble | preeclampsia | CONTRIBUTE | METASTASIS | ANGIOGENESIS | MECHANISM | soluble | RECEPTOR | endoglin | PLACENTAL EXOSOMES | CANCER | DEBRIS | PERIPHERAL VASCULAR DISEASE | HYPERTENSION | Tyrosine | Women | Complications and side effects | Blood circulation disorders | Preeclampsia | Research | Health aspects | Risk factors | Endothelium
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Serum concentrations of angiopoietin-2 and soluble fms-like tyrosine kinase 1 (SFlt-1) are associated with coagulopathy among patients with acute pancreatitis
by Dumnicka, Paulina and Kuśnierz-Cabala, Beata and Sporek, Mateusz and Mazur-Laskowska, Małgorzata and Gil, Krzysztof and Kuźniewski, Marek and Ceranowicz, Piotr and Warzecha, Zygmunt and Dembiński, Artur and Bonior, Joanna and DrożZdżZ, Ryszard
International Journal of Molecular Sciences, ISSN 1661-6596, 04/2017, Volume 18, Issue 4, pp. 753 - 753
In severe acute pancreatitis (SAP), systemic inflammation leads to endothelial dysfunction and activation of coagulation. Thrombotic disorders in acute... 
D-dimer | Angiopoietin-2 | Disseminated intravascular coagulation | Soluble fms-like tyrosine kinase 1 | Acute pancreatitis | angiopoietin-2 | soluble fms-like tyrosine kinase 1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | SPLANCHNIC VEIN-THROMBOSIS | ORGAN-FAILURE | SINGLE-CENTER-EXPERIENCE | EARLY SEPSIS | PRETREATMENT | INFLAMMATION | acute pancreatitis | CLINICAL-IMPLICATIONS | disseminated intravascular coagulation | ACENOCOUMAROL | Severity of Illness Index | Acute Disease | Prognosis | Prospective Studies | Fibrin Fibrinogen Degradation Products - metabolism | Humans | Middle Aged | Solubility | Logistic Models | Male | Biomarkers - blood | Pancreatitis - complications | C-Reactive Protein - metabolism | Aged, 80 and over | Blood Coagulation Disorders - blood | Female | Aged | Blood Coagulation Disorders - diagnosis | Vascular Endothelial Growth Factor Receptor-1 - blood | Angiopoietin-2 - blood | Blood Coagulation Disorders - complications | Tyrosine | C-reactive protein | Angiopoietin | Abnormalities | Coagulation | Markers | Pancreatitis | Disorders | Inflammation | Kinases | SAP protein | Patients | Thrombosis | Clotting | Hemostasis | Fibrinogen | Dimers | Hemostatics | Pancreas | Protein-tyrosine kinase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Fetal sexual dimorphism in systemic soluble fms‐like tyrosine kinase 1 among normotensive and preeclamptic women
by Taylor, Brandie D and Haggerty, Catherine L and Ness, Roberta B and Hougaard, David M and Skogstrand, Kristin and Roberts, James M and Olsen, Jørn
American Journal of Reproductive Immunology, ISSN 1046-7408, 11/2018, Volume 80, Issue 5, pp. e13034 - n/a
Problem A handful of studies report sexual dimorphism in the maternal angiogenic profile possibly influencing placental development and preeclampsia risk. This... 
fetal sex | soluble fms‐like tyrosine kinase 1 | preeclampsia | pregnancy | soluble fms-like tyrosine kinase 1 | PLACENTA | RISK | MODEL | IMMUNOLOGY | ANGIOGENIC FACTORS | BIOMARKERS | REPRODUCTIVE BIOLOGY | ADAM12 | COHORT | MATERNAL ASTHMA | GROWTH-FACTOR | Tyrosine | Statistical analysis | Fetuses | Sex | Dimorphism | Pre-eclampsia | Generalized linear models | Gestational age | Pregnancy | Angiogenesis | Endoglin | Body mass index | Placenta | Preeclampsia | Biomarkers | Blood pressure | Sexual dimorphism | Protein-tyrosine kinase | Smoking | Proteinuria
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Effect of Recombinant Placental Growth Factor 2 on Hypertension Induced by Full-Length Mouse Soluble fms-Like Tyrosine Kinase 1 Adenoviral Vector in Pregnant Mice
by Suzuki, Hirotada and Ohkuchi, Akihide and Matsubara, Shigeki and Takei, Yuji and Murakami, Masato and Shibuya, Masabumi and Suzuki, Mitsuaki and Sato, Yasufumi
Hypertension, ISSN 0194-911X, 11/2009, Volume 54, Issue 5, pp. 1129 - 1135
The first aim of our study was to develop a pregnant mouse model for preeclampsia using adenoviral vector containing mouse full-length soluble fms-like... 
Therapy | Animal models | Preeclampsia | Adenoviral vector | Soluble fms-like tyrosine kinase 1 | Placental growth factor | Vascular endothelial growth factor | soluble fms-like tyrosine kinase 1 | FACTOR VEGF | FLT-1 GENE | animal models | RAT | BEVACIZUMAB | therapy | SEVERE PREECLAMPSIA | EXTRACELLULAR DOMAIN | RANDOMIZED-TRIAL | RECEPTOR | adenoviral vector | preeclampsia | METASTATIC COLORECTAL-CANCER | placental growth factor | ANTIANGIOGENIC FACTORS | vascular endothelial growth factor | PERIPHERAL VASCULAR DISEASE | Pregnancy, Animal | Pre-Eclampsia - chemically induced | Humans | Probability | Hypertension - drug therapy | Reference Values | Membrane Proteins - pharmacology | Random Allocation | Mice, Inbred Strains | Pregnancy Proteins - pharmacology | Pregnancy | Animals | Pre-Eclampsia - drug therapy | Hypertension - chemically induced | Adenoviridae - genetics | Placenta Growth Factor | Female | Mice | Genetic Vectors | Vascular Endothelial Growth Factor A - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - pharmacology | Disease Models, Animal | Proteinuria | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
by Salahuddin, Saira and Lee, Young and Vadnais, Mary and Sachs, Benjamin P and Karumanchi, S. Ananth and Lim, Kee-Hak
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2007, Volume 197, Issue 1, pp. 28.e1 - 28.e6
The objective of this pilot study was to evaluate the clinical utility of soluble fms-like tyrosine kinase 1 (sFlt 1) and soluble endoglin (sEng) in the... 
soluble fms-like tyrosine kinase 1 | preeclampsia | hypertension in pregnancy | soluble endoglin | WOMEN | PLACENTAL GROWTH-FACTOR | OBSTETRICS & GYNECOLOGY | Diagnosis, Differential | Hypertension, Pregnancy-Induced - blood | Humans | Receptors, Cell Surface - blood | Hypertension, Pregnancy-Induced - diagnosis | Pre-Eclampsia - physiopathology | Pregnancy Trimester, Third | Case-Control Studies | Placenta - metabolism | Pregnancy | Endoglin | Antigens, CD - blood | Pilot Projects | Pre-Eclampsia - blood | Sensitivity and Specificity | Adult | Female | Pregnancy Complications, Cardiovascular - diagnosis | Vascular Endothelial Growth Factor Receptor-1 - blood | Pre-Eclampsia - diagnosis | Pregnancy Complications, Cardiovascular - blood | Hypertension | Pregnant women | Diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Longitudinal changes in maternal serum placental growth factor and soluble fms‐like tyrosine kinase‐1 in women at increased risk of pre‐eclampsia
by Khalil, A and Maiz, N and Garcia‐Mandujano, R and Penco, J. M and Nicolaides, K. H
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 03/2016, Volume 47, Issue 3, pp. 324 - 331
ABSTRACT Objectives To investigate longitudinal changes in maternal serum levels of placental growth factor (PlGF) and soluble fms‐like tyrosine kinase‐1... 
gestational hypertension | placental growth factor | blood pressure | pregnancy screening | pre‐eclampsia | soluble fms‐like tyrosine kinase‐1 | pre-eclampsia | soluble fms-like tyrosine kinase-1 | ENDOGLIN | ANGIOGENIC FACTORS | PREGNANCY | PREDICTION | OBSTETRICS & GYNECOLOGY | ACOUSTICS | PLASMA | ABNORMAL PLACENTATION | MOUSE MODEL | SUSPECTED PREECLAMPSIA | HYPERTENSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | FOR-GESTATIONAL-AGE | Prospective Studies | Hypertension, Pregnancy-Induced - blood | Humans | Placenta Growth Factor - blood | Biomarkers - blood | Gestational Age | Pregnancy | Pre-Eclampsia - blood | Sensitivity and Specificity | Adult | Female | Pregnancy Trimester, Second - blood | Vascular Endothelial Growth Factor Receptor-1 - blood | Early Diagnosis | Longitudinal Studies | Hypertension | Tyrosine | Phenols | Pregnant women | Preeclampsia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights